WVE-210201 Archives - Inside Precision Medicine

Inside Precision Medicine Wave to Use Deep Genomics’ AI Platform in Drug Discovery Collaboration

Wave Life Sciences will use Deep Genomics’ machine learning-driven biomedical platform to discover novel therapies for treating genetic neuromuscular disorders. Wave is already assessing a Duchenne muscular dystrophy (pictured) candidate in a gklobal Phase I study.[Courtney Young

Molecular Dx

Wave to Use Deep Genomics’ AI Platform in Drug Discovery Collaboration

April 10, 2018

Related Content

The Importance of Increasing Diversity in Clinical Trials

The Importance of Increasing Diversity in Clinical Trials

GSK Inks Two Deals with Relation for Fibrotic Diseases and Osteoarthritis

GSK Inks Two Deals with Relation for Fibrotic Diseases and Osteoarthritis

GBM Organoids Models Patient Response to CAR-T Cell Therapy in Real Time

GBM Organoids Models Patient Response to CAR-T Cell Therapy in Real Time

Improving Precision Oncology

Improving Precision Oncology